CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 120 enrolled / 120 target
Drug / intervention
Prototype dressing +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06831448
NCT06831448N/ACompletedHigh Momentum (7.0/mo)Completion was 15mo ago

An Open-label, Prospective, Comparative Human Participant Study to Evaluate the Clinically Acceptable Dressing Presence and Conformability Properties of a Prototype Multilayer Foam Dressing in Comparison to ALLEVYN◊ LIFE and Another Established Medical Device.

Smith & Nephew, Inc.·interventional·Posted Feb 18, 2025·Updated Jun 9, 2026

In Brief

A clinical study evaluating Prototype dressing, Marketed dressing 1, and 1 other intervention for Healthy. Completed, enrolled 120 participants across 1 site.

Signals

Enrolling ahead of pace

Detailed Summary

The purpose of this study is to evaluate a new prototype multilayer foam dressing on healthy, intact skin. The study will find out how well the new prototype dressing stays in place as well as other dressing performance and safety factors when compared to two corresponding, marketed dressings with a similar intended use profile and shape. The study will compare: 1. Prototype dressing vs Marketed dressing 1 on thighs and shins. 2. Prototype dressing vs Marketed dressing 2 on thighs and shins. The main aim of the study is to show that the new prototype dressing is not worse than the established marketed comparison dressings in terms of staying in place on human participants at 7 days. Dressings will have successfully stayed in place if the dressing edges have not lifted to reach the pad, and the pad is not exposed in any way. Additional data will be collected to further support product performance up to 7 days, including safety information and potential device issues.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedFeb 18, 2025
Enrollment StartJan 27, 2025
Primary CompletionMar 17, 2025
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 1.4 years ago

Arms & Interventions

Prototype dressing vs Marketed dressing 1other

The participant will be randomised to receive the comparison pair Prototype dressing vs Marketed dressing 1 on the left or right thigh/shin in a 1:1 ratio.

Device: Prototype dressingDevice: Marketed dressing 1
Prototype dressing vs Marketed dressing 2other

The participant will be randomised to receive the comparison pair Prototype dressing vs Marketed dressing 2 on the left or right thigh/shin in a 1:1 ratio.

Device: Prototype dressingDevice: Marketed dressing 2

Interventions

Prototype dressingdevice

Five-layer foam dressing. Size: 10cm x 10 cm. Topical application. Single use.

Marketed dressing 1device

Five-layer foam dressing. Size: 12.9cm × 12.9cm. Topical application. Single use.

Marketed dressing 2device

Five-layer foam dressing. Size: 10cm x 10 cm. Topical application. Single use.